Long-Term Safety and Efficacy of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-OLS)
Clinical trial NCT03617367 · COMPLETED
Trial details
- NCT number
- NCT03617367
- Sponsor
- Revance Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-05
- Primary completion
- 2021-05-25
- Enrollment
- 357
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.